journal article·2011-09Open access

Glass and Glass‐Ceramic Technologies to Transform the World

Larry L. Hench

Abstract

This presentation is an overview of the findings from J une 21 to 22, 2010 A merican C eramic S ociety L eadership S ummit and a personal perspective on the economic issues and technical feasibility of achieving breakthrough technologies in the business segments of E nergy and H ealthcare. The top 10 rankings from an extensive listing of 100 potentially important ceramic, glass and glass–ceramic technologies were all in the E nergy and H ealthcare S ectors of business. Innovative technologies that have the potential for being world‐changing are discussed, including T ransforming T echnology for E nergy N o. 1: I nnovative E nergy S torage D evices; T ransforming T echnology for H ealthcare N o. 1: B ioactive M aterials for R egeneration of T issues; N o. 2: L ocalized T herapies for C ancer and A utoimmune D iseases; N o. 3: T issue E ngineering of S oft T issues; N o. 4: S tem C ell E ngineering; N o. 5: P reventative M edicine.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Facial Trauma and Fracture Management · Dental Implant Techniques and Outcomes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Materials Science and Engineering University of Florida Gainesville Florida 32605

Office of the Vice President University of Central Florida Orlando Florida

King's College/Guy's Hospital School of Dentistry University of London London UK

References (93)

Show source-provided references
1. F.WangandL. L.Hench “Large Sol‐Gel SiO2Monoliths Containing Transition Metals and Their Production ” U.S. Patent 4851373 (dated 07/25) US Patent and Trademark Office Washington D.C. 1989.
2. 10.1021/cr00099a00310.1021/cr00099a003 ↗
3. 10.1146/annurev.ms.20.080190.00141310.1146/annurev.ms.20.080190.001413 ↗
4. 10.1007/978-1-4615-2750-3_310.1007/978-1-4615-2750-3_3 ↗
5. Hench L. L. · 1998
6. 10.1007/978-1-4757-3058-610.1007/978-1-4757-3058-6 ↗
7. 10.1002/chem.20080063910.1002/chem.200800639 ↗
8. Nanoporous Carbon Supercapacitors: From Double Layer, to Double Cylinder, to Wire in Cylinder
9. 10.1126/science.113219510.1126/science.1132195 ↗
10. 10.1098/rsif.2010.0151.focus10.1098/rsif.2010.0151.focus ↗
11. 10.1111/j.1151-2916.1991.tb07132.x10.1111/j.1151-2916.1991.tb07132.x ↗
12. Hench L. L. · 1996
13. 10.1126/science.106740410.1126/science.1067404 ↗
14. 10.1038/nmat244110.1038/nmat2441 ↗
15. 10.1002/jbm.82005061110.1002/jbm.820050611 ↗
16. Bioglass: A Short History and Bibliography
17. 10.1002/jab.77003020810.1002/jab.770030208 ↗
18. 10.1007/s00223000113410.1007/s002230001134 ↗
19. 10.1007/s10019000005510.1007/s100190000055 ↗
20. 10.1006/bbrc.2000.350310.1006/bbrc.2000.3503 ↗
21. 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.0.CO;2-D10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.0.CO;2-D ↗
22. Gene Activating Glasses
23. Glass and Genes: The 2001 W. E. S. Turner Memorial Lecture
24. 10.1016/j.biomaterials.2003.07.00110.1016/j.biomaterials.2003.07.001 ↗
25. 10.1016/j.biomaterials.2006.11.02210.1016/j.biomaterials.2006.11.022 ↗
26. 10.1002/jbm.b.3045510.1002/jbm.b.30455 ↗
27. 10.1089/ten.2004.10.101810.1089/ten.2004.10.1018 ↗
28. 10.1089/ten.2005.11.47910.1089/ten.2005.11.479 ↗
29. 10.1002/jbm.b.3024910.1002/jbm.b.30249 ↗
30. Effect of Bioglass® Repeat Dosage on Mineralization of Embryonic Bone In Vitro
31. 10.1002/jbm.b.1007110.1002/jbm.b.10071 ↗
32. 10.1016/j.biomaterials.2005.07.01710.1016/j.biomaterials.2005.07.017 ↗
33. 10.1098/rsta.2005.168910.1098/rsta.2005.1689 ↗
34. 10.1016/j.scriptamat.2004.08.01410.1016/j.scriptamat.2004.08.014 ↗
35. 10.1179/17436760522501103410.1179/174367605225011034 ↗
36. Mechanical Behavior of Bioactive Glass‐Polyvinyl Alcohol Hybrid Foams Obtained by the Sol‐Gel Process
37. Clinical Use of a Bioactive Glass Particulate in the Treatment of Human Osseous Defects
38. 10.1902/jop.1998.69.9.102710.1902/jop.1998.69.9.1027 ↗
39. 10.1016/B978-0-08-042144-5.50069-810.1016/B978-0-08-042144-5.50069-8 ↗
40. 10.1902/jop.2001.72.6.73010.1902/jop.2001.72.6.730 ↗
41. 10.1053/joms.2001.2752410.1053/joms.2001.27524 ↗
42. 10.1902/jop.2001.72.2.12510.1902/jop.2001.72.2.125 ↗
43. 10.1902/jop.2003.74.6.89910.1902/jop.2003.74.6.899 ↗
44. 10.1097/BPO.0b013e318168d1d410.1097/BPO.0b013e318168d1d4 ↗
45. Bioactive Glass versus Autogenous Iliac Crest Bone Graft in Adolescent Idiopathic Scoliosis Surgery
46. 10.1111/j.2041-1294.2010.00001.x10.1111/j.2041-1294.2010.00001.x ↗
47. 10.1097/01.RVI.0000236744.34720.7310.1097/01.RVI.0000236744.34720.73 ↗
48. 10.1053/jhep.2001.2104110.1053/jhep.2001.21041 ↗
49. 10.1111/j.1151-2916.1987.tb04901.x10.1111/j.1151-2916.1987.tb04901.x ↗
50. 10.1002/jbm.82027101010.1002/jbm.820271010 ↗
51. 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E ↗
52. 10.2214/AJR.06.070610.2214/AJR.06.0706 ↗
53. 10.1002/jso.2060910.1002/jso.20609 ↗
54. 10.1245/s10434-009-0454-010.1245/s10434-009-0454-0 ↗
55. 10.4028/www.scientific.net/KEM.94-95.18110.4028/www.scientific.net/KEM.94-95.181 ↗
56. Microspheres and Microworlds
57. L. K.Heung R. F.Schumacher andG. C.Wicks “Hollow Porous Wall Microspheres” U.S. Patent Filed 10/21/05 PCT filed 10/17/06.
58. Gorustovich A. A. · 2011
59. 10.1002/jbm.a.1058710.1002/jbm.a.10587 ↗
60. 10.1016/S0266-3538(03)00275-610.1016/S0266-3538(03)00275-6 ↗
61. 10.1016/j.biomaterials.2004.01.04310.1016/j.biomaterials.2004.01.043 ↗
62. 10.1016/j.biomaterials.2003.09.08110.1016/j.biomaterials.2003.09.081 ↗
63. 10.4028/www.scientific.net/MSF.426-432.17910.4028/www.scientific.net/MSF.426-432.179 ↗
64. 10.1089/ten.2005.11.76810.1089/ten.2005.11.768 ↗
65. 10.1002/jbm.a.3043310.1002/jbm.a.30433 ↗
66. 10.1007/s11095-007-9508-910.1007/s11095-007-9508-9 ↗
67. 10.1089/ten.teb.2009.041610.1089/ten.teb.2009.0416 ↗
68. 10.1016/j.actbio.2008.08.00310.1016/j.actbio.2008.08.003 ↗
69. Hench L. L. · 201110.1142/p713 ↗
70. Pano J. · 2006
71. 10.1021/ar900226q10.1021/ar900226q ↗
72. 10.1016/j.actbio.2008.09.01310.1016/j.actbio.2008.09.013 ↗
73. 10.1038/sj.gt.330265110.1038/sj.gt.3302651 ↗
74. 10.1111/j.1749-6632.2010.05495.x10.1111/j.1749-6632.2010.05495.x ↗
75. 10.1142/p55210.1142/p552 ↗
76. The Use of Murine Embryonic Stem Cells, Alginate Encapsulation, and Rotary Microgravity Bioreactor in Bone Tissue Engineering
77. 10.1073/pnas.090544510710.1073/pnas.0905445107 ↗
78. NovaMin Technology
79. NovaMin and Tooth Sensitivity‐An Overview
80. NovaMin and Dentinal Hypersensitivity—In Vitro Evidence of Efficacy
81. The Role of Ionic Release from NovaMin (Calcium Sodium Phosphosilicate) in Tubule Occlusion: An Exploratory Study using Radio‐Labeled Isotopes
82. A Clinical Study of the Effect of Calcium Sodium Phosphosilicate on Dentin Hypersensitivity—Proof of Principle
83. A Randomized Controlled Clinical Study Evaluating the Efficacy of Two Desensitizing Dentifrices
84. A Clinical Study Comparing Oral Formulations Containing 7.5% Calcium Phosphosilicate (NovaMin), 5% Potassium Nitrate and 0.4% Stannous Fluoride for the Management of Dentin Hypersensitivity
85. 10.1016/j.biomaterials.2011.01.00410.1016/j.biomaterials.2011.01.004 ↗
86. 10.1016/j.actbio.2011.03.01610.1016/j.actbio.2011.03.016 ↗
87. 10.1002/jbm.a.3307210.1002/jbm.a.33072 ↗
88. 10.1016/j.actbio.2008.03.00710.1016/j.actbio.2008.03.007 ↗
89. 10.1201/b1169610.1201/b11696 ↗
90. Cotton Candy that Heals?
91. 10.1016/j.biomaterials.2004.10.02110.1016/j.biomaterials.2004.10.021 ↗
92. 10.1089/ten.tea.2008.020310.1089/ten.tea.2008.0203 ↗
93. 10.1111/j.1151-2916.1998.tb02540.x10.1111/j.1151-2916.1998.tb02540.x ↗